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Abstract
C-reactive protein (CRP) is a component of non-specific immune defense and is a reliable marker
of low-grade inflammation involved in obesity, type 2 diabetes and cardiovascular disease.
Genome-wide association studies (GWAS) in middle-aged and elderly populations, predominantly
of European descent, demonstrated associations of CRP levels with SNPs at several loci. To
examine whether the variants identified are replicated in Filipino young adults, we applied Tobit
regression models to study the association of plasma CRP with 12 SNPs at seven loci in a cohort
of 1,691 Filipino young adults (aged 21.5 ± 0.3 years) from the Cebu Longitudinal Health and
Nutrition Survey (CLHNS). SNPs in or near CRP (P = 3.2 × 10-11), HNF1A, IL6R, APOE-APOC1
and LEPR showed significant associations (P < 0.05) and together explained 4.8% of the total
variation in CRP. Modest interactions were observed between LEPR rs1892534 and waist
circumference (uncorrected Pinteraction = 0.020) and between APOE rs769449 and pathogen
exposure (uncorrected Pinteraction = 0.0073) in models predicting CRP. Our results demonstrated
that variants in several loci are significantly associated with plasma CRP in Filipino young adults,
suggesting shared genetic influences on circulating CRP across populations and age groups.
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INTRODUCTION
C-reactive protein (CRP) is a component of the acute-phase response and a marker of
chronic inflammation, which plays important roles in the co-morbidities that accompany
obesity, dyslipidemia, type 2 diabetes and cardiovascular diseases1-4. In a large US-based
study, an estimated 35-40% of the variability in circulating CRP was explained by genetic
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variation5. Studies using a candidate gene strategy have described associations linking
circulating CRP with several SNPs and haplotypes in the gene regions of CRP, LEPR and
APOE6-8. A prior genome-wide association (GWA) study based on individuals of European
ancestry from the women's genome health study (WGHS) has provided evidence of
associations between CRP and SNPs at seven genetic loci, including CRP, HNF1A, LEPR,
IL6R, APOE, GCKR and 12q23.2, together accounting for 10.1% of the total variation in
circulating CRP in this population9. Similar findings of association were reported by
subsequent GWA studies conducted in individuals of middle-aged and elderly European
descent10-11 and in Japanese12. A recent meta-analysis confirmed the reported 7 loci and
identified 11 additional loci associated with CRP levels13.
Quantitative traits such as CRP concentrations are known to be influenced by both genetic
and environmental factors, and interactions between them are likely to be important
predictors as well14. Evidence exists that an interaction between adiposity and CRP gene
variants influences CRP levels. An interaction analysis conducted in Taiwanese noted that
the association between CRP haplotypes and CRP level predominantly occurred in obese
subjects15, and a CRP variant by adiposity interaction analysis in Europeans showed that the
correlated increase in CRP levels with adiposity was accentuated by the presence of the CRP
rs1205 G allele16.
Genetic background may vary across populations, and the genetic contribution of identified
variants on circulating CRP remains unclear in populations of non-European descent. The
purpose of this study is to assess whether the CRP-associated loci identified in Europeans
are associated with plasma CRP in a cohort of Filipino young adults living in the Metro
Cebu area of the Philippines. In light of the roles of infectious agents17 and adipose tissue18
in up-regulating inflammatory pathways, prior work in this population demonstrated that
CRP levels were influenced by a dual burden of environmental pathogenicity and central
adiposity19-21. Thus, we also aim to determine whether measures of individual adiposity and
household-level pathogenicity modify any effects of these polymorphisms on CRP levels.
MATERIALS AND METHODS
Samples and data come from the Cebu Longitudinal Health and Nutrition Survey (CLHNS),
an on-going community-based cohort study of births between May 1, 1983 and April 30,
1984. The CLHNS is based in Metro Cebu, Philippines, which encompasses three central
cities within Cebu province as well as contiguous peri-urban and rural municipalities. The
original study design and recruitment protocols have been previously described in detail22.
Written informed consent was obtained from all participants, and study protocols were
approved by the University of North Carolina Institutional Review Board for the Protection
of Human Subjects. In the 2005 survey, the available sample included 1,779 Filipino young
adults. A pathogen exposure score was constructed based on the mean value of five
interviewer-assigned variables, each scored on a three point scale (0=low exposure,
1=moderate, 2=high): cleanliness of the food preparation area, means of garbage disposal,
presence of excrement near the house, level of garbage and excrement present in the
neighborhood surrounding the household19. In addition, to control for any effects of active
infection on CRP levels, participants were asked whether they were experiencing any
symptoms of infection at the time of blood collection. Reported symptoms included runny
nose, cough, fever, diarrhea, sore throat and the more general categories of flu, cold and
sinusitis20.
Overnight fasting blood samples were obtained at the 2005 survey and collected into EDTA-
coated tubes. Plasma CRP concentration was determined using a high sensitivity
immunoturbidimetric method (Synchron LX20 with lower detection limit of 0.1mg/L;
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Beckman Coulter, Fullerton, CA) with between-assay CVs < 7.6 across the assay range19.
Following AHA/CDC guidelines, participants with CRP level > 10 mg/L were interpreted as
having an acute infection23 and were therefore excluded from analyses. The final sample set
for analysis included 1,691 unrelated CLHNS young adults with complete data on plasma
CRP, all genotypes and covariates.
Selection of SNPs for analyses was based on published data regarding their association with
CRP concentrations9-10. At the seven loci (CRP, LEPR, IL6R, GCKR, 12q23.2, HNF1A and
APOE-APOC1) for which we have > 80% power to detect the reported variance explained
by SNPs, we selected SNPs with the strongest evidence of association at a given locus or
with potential functional significance based on annotation24-25. The nine SNPs included
rs1205 (CRP), rs3091244 (CRP), rs1892534 (LEPR), rs2228145 (IL6R), rs1260326
(GCKR), rs10778213 (12q23.2), rs1169288 (HNF1A), rs7310409 (HNF1A) and rs769449
(APOEAPOC1). Three additional SNPs in APOE or APOC1 were selected to better
characterize this locus. SNPs rs429358 and rs7412 were selected to construct the reported
APOE haplotypes ε2 (rs429358-rs7412: T-T), ε3 (rs429358-rs7412: T-C), and ε4 (rs429358-
rs7412: C-C)8. SNP rs4420638 in APOC1 was selected based on reproducible evidence of
association with CRP level in previous reports11-13.
Genotyping was performed using TaqMan fluorogenic 5' nuclease assays (Applied
Biosystems) using an ABI PRISM® 7900 system. The triallelic SNP rs3091244 was
genotyped based on two separate assays (C/T and C/A)26, and the final genotypes were
assigned as shown in Supplementary Table 1. Genotyping success rates for all assays were >
96.5%, and all SNPs were in agreement with Hardy-Weinberg equilibrium (P > 0.1). SNP
rs4420638 in APOC1 was imputed using MACH27 from MetaboChip (Illumina, San Diego,
CA, USA) SNP genotypes in CLHNS young adults [Damien C. Croteau-Chonka, et.al.,
manuscript submitted] based on CEU, CHB and JPT haplotypes created from the 1000
Genomes Project pilot (June 2011 data release). Based on the high imputation quality (r2 =
0.96) of rs4420638, we used the posterior expected genotypes in statistical analyses.
A total of 574 (33.9%) individuals among the 1,691 CLHNS young adults had CRP
concentrations below the detectable level (0.1 mg/L), and log-CRP concentrations produced
a left-censored distribution. Given the markedly skewed distribution of CRP concentrations
and the presence of many values < 0.1, we used Tobit regression that applies linear
regression to a mixture of censored discrete data and normally distributed continuous
distributions28 to test association between natural log-transformed CRP (left-censored at
value of -3, corresponding to natural log of 0.05) and genotype in the CLHNS young adults.
In addition, we applied linear regression, in which CRP values were natural log-transformed
after adding the constant 0.10. In initial analysis for main effects, an additive genetic model
was assumed. Sex, pathogenic score and infection status were included as covariates. In
secondary analyses, both models were further adjusted for waist circumference to examine
whether the associations of SNPs and plasma CRP were mediated by central adiposity.
Interactions between SNPs and waist circumference and between SNPs and pathogen
exposure score were evaluated in Tobit regression models, accounting for the same
covariates used in the main effect analyses. Waist circumference and pathogenic score were
treated as dichotomous variables, using the medians (waist circumference < 69 or ≥ 69 cm
and pathogen exposure score <0.5 or ≥ 0.5) as the threshold to stratify the study samples.
We further assessed the combined effect of multiple SNPs on plasma CRP using a
cumulative genotype score as an independent variable. The cumulative genotype score was
calculated based on the number of alleles associated with elevated CRP level, weighted by
the fitted linear regression model coefficients. A total of five SNPs (CRP-rs1205, LEPR-
rs1892534, IL6R-rs2228145, HNF1A-rs7310409 and APOE-rs429358) representing each of
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the five CRP-associated loci in the CLHNS were used for the combined effect estimation.
Individuals with genotypes available for all the 5 selected SNPs (n = 1,592) were
categorized into quintiles based on the cumulative genotype score.
All analyses for association with single SNPs were performed with SAS version 9.2 (SAS
Institute, Cary, NC, USA). The ‘haplo.score’ and ‘haplo.glm’ functions implemented in the
‘haplo.stats’ R package were applied for haplotype analysis.
RESULTS
Twelve SNPs at seven loci were investigated in 1,691 CLHNS young adults (Table 1).
Based on the results from Tobit regression models, we observed evidence of significant
association with plasma CRP for SNPs at five loci, including CRP (P for rs1205 = 3.2 ×
10-11 and P for rs3091244 = 5.6 × 10-10), HNF1A (P for rs7310409 = 4.1 × 10-5 and P for
rs1169288 = 1.0 × 10-4), IL6R (P for 2228145 = 6.2 × 10-4), APOE-APOC1 (P for rs769449
= 0.0068, P for rs429358 = 0.0060, and P for rs4420638 = 0.044), and LEPR (P for
rs1892534 = 0.018), all showing the same direction of effect as previously reported9, 13
(Table 2). The associations for variants at CRP, HNF1A and IL6R remained significant after
Bonferroni correction for multiple testing (P < 0.0042, 0.05/12 tests). No evidence for
association was observed for variants at GCKR (P = 0.46 for rs1260326) or the gene desert
region of 12q23.2 (P = 0.73 for rs10778213). A third SNP in the APOE gene, rs7412,
showed no association with CRP level in CLHNS young adults (P = 0.51). Consistent
results for association were observed using linear regression models (data not shown). We
further examined whether these associations with CRP level were affected by adjustment for
waist circumference. None of the associations substantially changed, suggesting that the
genetic associations with plasma CRP were independent of central adiposity (Supplementary
Table 2).
An association between CRP level and APOE haplotype consisting of the SNPs rs429358
and rs7412 was previously reported in middle-aged and elderly Caucasians8. Our results
provided confirmatory evidence of the haplotype association in this cohort of Filipino young
adults (Table 3). Haplotype analysis based on score statistic revealed an overall association
between haplotypes and CRP levels (global P value = 0.018). Specifically, the APOE ε4
haplotype with a frequency of 0.099 was significantly associated with lower CRP level (P =
0.0047). Complementary analysis that assessed the effect on CRP level of each additional
copy of the specific haplotype compared to the homozygote reference haplotype found that
the APOE ε4 haplotype was significantly associated with decreased plasma CRP (β =
-0.210, P = 5.4 × 10-3) compared to the most common APOE ε3 haplotype. We next
performed conditional analysis at APOE-APOC1 to examine whether the associated SNPs
represent a single signal. Reciprocal conditional analysis on APOC1-rs4420638 and APOE-
rs429358 (LD r2 = 0.51) showed that the effect of association with rs4420638 was
substantially attenuated (Pconditional = 0.76) whereas the association with rs429358 remained
significant (Pconditional = 0.0093). Therefore, the SNPs at the APOE-APOC1 cluster appear
to represent a single signal best represented by APOE-rs429358.
We next investigated whether the genetic associations with plasma CRP are modified by
waist circumference or pathogen exposure (Supplementary Table 3), both of which are
predictors of baseline CRP level. Modest evidence was detected for the interaction of waist
circumference with rs1892534 at LEPR (uncorrected Pinteraction = 0.020). In a secondary
analysis stratifying by waist circumference above or below the median value, the estimated
increase in log-CRP level for each additional C allele of rs1892534 was 0.232 (P = 0.0062)
in individuals with smaller waist circumference and 0.015 (P = 0.86) in those with larger
waist circumference. We also observed evidence for interaction between APOE variant
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rs769449 and pathogen exposure on plasma CRP (uncorrected Pinteraction = 0.0073). When
stratified analysis was conducted, we found that the significant and strong association
between CRP level and the APOE variant was predominantly observed in individuals with
lower exposure to a pathogenic environment (β = 0.419, P = 6.8 × 10-5) compared to those
with higher exposure (β = 0.017, P = 0.88). Given that the observed interaction was not
significant after Bonferroni correction (corrected Pinteraction > 0.0045, 0.05/ 11 tests), further
studies in larger populations are warranted.
We observed no evidence of multiplicative SNP-SNP interaction among variants CRP-
rs1205, LEPR-rs1892534, IL6R-rs2228145, HNF1A-rs7310409 and APOE-rs429358 (all
uncorrected Pinteraction > 0.12). In assessing the combined effects of multiple SNPs on
plasma CRP, we observed a dose response. Individuals carrying a greater number of alleles
associated with elevated level of CRP had increased circulating CRP level (P for trend = 1.0
× 10-17, Figure 1). The geometric mean of plasma CRP in the group of individuals in the
highest quintile (Q5) was 0.648 mg/L (SE = 0.048), a 2.4-fold increase compared to that in
the lowest quintile group (geometric mean = 0.273, SE = 0.019).
DISCUSSION
In this study of Filipino young adults, we replicated associations for plasma CRP with
several variants previously identified in middle-aged or elder Europeans9. SNPs at five loci
of CRP, HNF1A, LEPR, IL6R, APOE-APOC1 were significantly associated with CRP level
and together explained 4.8% of the variance in CRP in this population. In addition, modest
interactions were observed between LEPR rs1892534 and waist circumference and between
APOE rs769449 and pathogen exposure in models predicting plasma CRP, suggesting that
the impact of these variants may be contingent upon environmental exposures.
In past studies, variants at the CRP locus, which encodes the CRP protein, were
reproducibly reported to show significant association with circulating CRP not only in
populations of European ancestry, but also in Asians such as Chinese and Japanese15, 29.
Specifically, the triallelic SNP rs3091244 was suggested to be functionally relevant30. In our
Filipino young adult sample, the SNPs rs1205 and rs3091244 at the CRP gene region
showed the strongest associations with plasma CRP, consistent with the previous findings
from candidate gene and GWAS9-10, 15. We also observed a strong association between
plasma CRP and HNF1A variants rs7310409 and rs1169288. Because the protein HNF1A is
involved in modulating CRP gene expression by directly binding to its promoter31, the gene
region of HNF1A had convincing prior evidence of association with CRP as a candidate
gene and was further confirmed by GWAS in European-based populations9-10. We also
replicated associations with CRP related variants at IL6R32, APOE8, APOC113, and LEPR7,
providing the first confirmation of genetic association for these loci in a young Asian
population.
We did not find evidence for an association between plasma CRP and the SNP in GCKR
(rs1260326) or the intergenic SNP 12q23.1-rs10778213, despite our >95% power to detect
the previously reported variance explained by these SNPs9. Similar to our results, the
association with these SNPs failed to reach significant levels in a prior GWAS conducted in
the Pharmacogenomics and Risk of Cardiovascular Disease (PARC) study10, thus
suggesting that the association for variants at these loci might be population-specific. We
did not test additional CRP associated loci reported by a recent meta-analysis of GWA
studies13 because our study was poorly powered (< 35%) to detect the reported variance
explained by those SNPs. In addition, given the relatively younger age of our study sample
compared to those previously reported9, the potential interactive influence between gene and
age may also partially explain the discrepancy. Furthermore, because the environmental
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factors and behavior such as infection, smoking, diet pattern and physical activity may
contribute to baseline CRP variation33, we cannot exclude the possibility that the long-term
exposure to certain environmental factors may accentuate the genetic susceptibility on CRP
level in middle-aged or elderly populations.
In conclusion, our results demonstrate that SNPs at CRP, HNF1A, IL6R, APOE-APOC1 and
LEPR are associated with plasma CRP in a sample of Filipino young adults. This study
expands our understanding of the genetic associations with CRP level to a younger
population of mostly non-European ancestry and suggests a shared genetic influence
between ethnic groups.
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CRP level increases with genotype score in 1,592 CLHNS Filipino young adults. The
cumulative genotype score was calculated based on the number of alleles associated with
elevated CRP level, weighted by the fitted linear regression model coefficients. Individuals
with genotypes available from five selected SNPs (CRP-rs1205, LEPR-rs1892534, IL6R-
rs2228145, HNF1A-rs7310409 and APOE-rs429358) were categorized into quintiles based
on the cumulative genotype score.
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Table 1
Characteristics of the CLHNS young adult cohort
Females (n=799) Males (n=892) Total (n=1,691)
Age (years) 21.5 ± 0.3 21.5 ± 0.3 21.5 ± 0.3
CRP (mg/L) 0.3 (0, 1.0) 0.2 (0, 0.8) 0.2 (0, 0.9)
Waist circumference (cm) 68.0 ± 7.6 72.2 ± 7.5 70.3 ± 7.8
BMI (kg/m2) 20.4 ± 3.2 21.1 ± 3.1 20.8 ± 3.2
Symptoms of infection (%) 13.9 12.8 13.3
Pathogen exposure score 0.54 ± 0.39 0.55 ± 0.40 0.54 ± 0.40
Data are mean ± SD, median (25th percentile, 75th percentile) or %.
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